Moneycontrol Bureau
Shares of Celestial Biolabs climbed 8 percent intraday Tuesday ahead of patented anti-diabetic product launch.
After the hugely successful launch of its patented arthritis management product Cadalmin GAe, the Hyderabad-based bio-pharmaceutical company, Celestial is set to launch its latest anti-diabetic product, said the company in its filing to the exchange.
The product is expected to be a breakthrough in research and in the management of diabetes, it added.
The company is in the process of launching this natural sea based 100 percent vegetarian product tentatively by April 2015.
At 11:53 hours IST, the stock was quoting at Rs 50.75, up Rs 3.35, or 7.07 percent on the Bombay Stock Exchange.
Posted by Sunil Shankar Matkar
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
